Alessandro Piergentili

University of Camerino

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (15)

Hideaki Yano

Northeastern University

UNITED STATES

View details

Loredana CAPPELLACCI

Associate Professor

University of Camerino

ITALY

View details

Wilma Quaglia

ITALY

View details

Thomas M. Keck

Associate Professor, Dept. Chair

Rowan University

UNITED STATES

View details

Dimitrios Agas

University of Camerino

ITALY

View details

LAURA ZEPPA

University of Camerino

ITALY

View details

Maria Vittoria Micioni Di Bonaventura

Assistant Professor of Pharmacology

Università degli Studi di Perugia Dipartimento di Scienze Farmaceutiche

ITALY

View details

Fabio Del Bello

University of Camerino

ITALY

View details

Carlo Cifani

ITALY

View details

Iole Venditti

Roma Tre University

ITALY

View details

Carlo Santini

Professore ordinario

Università degli Studi di Torino

ITALY

View details

Alessandro Bonifazi

Associate Professor

University of Texas Medical Branch at Galveston

UNITED STATES

View details

Gianfabio Giorgioni

Assistant Professor

University of Camerino

ITALY

View details

Maria Giovanna Sabbieti

ITALY

View details

Emanuela Micioni Di Bonaventura

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alessandro Piergentili

Research Interests

Explore related searches

Contact this professor

Articles (11)

Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma

New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma

Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma

Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders

Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor Effects

Highly Potent and Selective Dopamine D<sub>4</sub> Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma.

Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor

Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D3 Receptor-Selective or Multitarget Bitopic Ligands Potentially Useful for Central Nervous System Disorders

Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior

Novel Highly Potent and Selective Sigma1 Receptor Antagonists Effectively Block the Binge Eating Episode in Female Rats

Novel Potent Muscarinic Receptor Antagonists: Investigation on the Nature of Lipophilic Substituents in the 5- and/or 6-Positions of the 1,4-Dioxane Nucleus

Collaborators (15)

Hideaki Yano

Loredana CAPPELLACCI

Wilma Quaglia

Thomas M. Keck

Dimitrios Agas

LAURA ZEPPA

Maria Vittoria Micioni Di Bonaventura

Fabio Del Bello

Carlo Cifani

Iole Venditti

Carlo Santini

Alessandro Bonifazi

Gianfabio Giorgioni

Maria Giovanna Sabbieti

Emanuela Micioni Di Bonaventura

Make your next move.